About this trial

This is a prospective, randomized clinical trial evaluating the efficacy and safety of two techniques for repeat catheter ablation in patients with recurrent atrial fibrillation (AF): thermal energy ablation (radiofrequency) and non-thermal electroporation (pulsed field ablation), both guided by 3D imaging systems.

Patients undergoing repeat AF ablation will be randomly assigned to receive either thermal or electroporation ablation, performed according to standard hospital protocols. No additional invasive procedures are required. Following the ablation, participants will attend follow-up visits at 3, 6, and 12 months, including medical history review, physical examination, 12-lead ECG, and 24-hour Holter monitoring. Unscheduled ECG assessments will also be available if arrhythmia symptoms occur.

All study-related procedures are non-invasive and align with routine post-ablation care. Risks are limited to those typically associated with standard AF ablation procedures.

The main benefit of participation is close, structured follow-up by experienced electrophysiologists, allowing for early detection of arrhythmia recurrence and timely medical intervention when necessary.

Participant confidentiality and data protection will be ensured in accordance with GDPR regulations.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Pulsed field ablation of reccurent atrial arrythmia
  • Radiofrequency ablation of reccurent atrial arrythmia (standard of care)

Treatment groups

250 Participants
are divided into 2 treatment groups

Locations

1
Clinical Department of Cardio, Jan Mikulicz Radecki University Hospital in Wroclaw50-556, Wroclaw Poland

Sponsors and collaborators

Wroclaw Medical University

Lead sponsor